Cellyrix Therapeutics

TargetingTumor Heterogeneity

Active Pre-Funding Startup Rehovot Founded 2024-12

At Cellyrix, we are on a mission to introduce a new modality into cancer treatment by harnessing the power of cutting-edge technologies. Tumor heterogeneity, a fundamental aspect of cancer, lies at the heart of treatment challenges such as therapy resistance, metastasis, and relapse. Leveraging breakthroughs in single-cell sequencing and artificial intellig…

SectorHealth Tech & Life Sciences
StagePre-Funding
Employees5
Founded2024-12
HQRehovot
Confidence75
Sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & Development
Technology
Artificial IntelligenceGenerative AIBiologicalsMolecules
Target customers
Healthcare & Life SciencesLife SciencesPharmaceuticals